1.
Najm FJ, Strand C, Donovan KF, et al. Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens. Nat Biotechnol. 2018;36(2):179-189. doi:10.1038/nbt.4048.
1.
Fenteany G, Schreiber SL. Lactacystin, proteasome function, and cell fate. J Biol Chem. 1998;273(15):8545-8.
1.
Bilimoria PM, Stevens B. Microglia function during brain development: New insights from animal models. Brain Res. 2015;1617:7-17. doi:10.1016/j.brainres.2014.11.032.
1.
Maass PG, Barutcu R, Shechner DM, Weiner CL, Melé M, Rinn JL. Spatiotemporal allele organization by allele-specific CRISPR live-cell imaging (SNP-CLING). Nat Struct Mol Biol. 2018;25(2):176-184. doi:10.1038/s41594-017-0015-3.
1.
George RE, Sanda T, Hanna M, et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature. 2008;455(7215):975-8. doi:10.1038/nature07397.
1.
Liu Y, Asnani A, Zou L, et al. Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase. Sci Transl Med. 2014;6(266):266ra170. doi:10.1126/scitranslmed.3010189.
1.
Chen E, Ahn JS, Sykes DB, et al. RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability. Cell Rep. 2015;13(11):2345-52. doi:10.1016/j.celrep.2015.11.037.
1.
van Ham TJ, Kokel D, Peterson RT. Apoptotic cells are cleared by directional migration and elmo1- dependent macrophage engulfment. Curr Biol. 2012;22(9):830-6. doi:10.1016/j.cub.2012.03.027.
1.
Ellis CN, LaRocque RC, Uddin T, et al. Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera. Infect Immun. 2015;83(3):1089-103. doi:10.1128/IAI.02765-14.
1.
Neel VA, Todorova K, Wang J, et al. Sustained Akt Activity Is Required to Maintain Cell Viability in Seborrheic Keratosis, a Benign Epithelial Tumor. J Invest Dermatol. 2016;136(3):696-705. doi:10.1016/j.jid.2015.12.023.